Rolf Rau

4.3k total citations · 2 hit papers
39 papers, 3.3k citations indexed

About

Rolf Rau is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Rolf Rau has authored 39 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Rheumatology, 10 papers in Hematology and 8 papers in Immunology. Recurrent topics in Rolf Rau's work include Rheumatoid Arthritis Research and Therapies (35 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Rolf Rau is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (35 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Rolf Rau collaborates with scholars based in Germany, United States and Netherlands. Rolf Rau's co-authors include A. Zink, Joachim Listing, G. Herborn, Siegfried Wassenberg, Anja Strangfeld, Jörn Kekow, Erika Gromnica‐Ihle, Roger Aitchison, Paul Emery and Michael Doherty and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Current Opinion in Rheumatology.

In The Last Decade

Rolf Rau

39 papers receiving 3.2k citations

Hit Papers

Treatment of rheumatoid arthritis with recombinant human ... 1998 2026 2007 2016 1998 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf Rau Germany 23 2.4k 963 770 405 394 39 3.3k
Arnaud Constantin France 30 1.9k 0.8× 605 0.6× 829 1.1× 427 1.1× 329 0.8× 120 3.1k
J. Nam United Kingdom 21 2.4k 1.0× 887 0.9× 723 0.9× 256 0.6× 414 1.1× 57 3.0k
John J. Cush United States 31 2.5k 1.1× 1.2k 1.2× 1.6k 2.1× 529 1.3× 399 1.0× 59 4.3k
Matija Tomšič Slovenia 28 1.7k 0.7× 606 0.6× 627 0.8× 318 0.8× 441 1.1× 131 2.8k
Scott W. Baumgartner United States 16 1.4k 0.6× 1.0k 1.0× 766 1.0× 343 0.8× 232 0.6× 18 2.5k
Daniel Burge United States 14 2.6k 1.1× 1.5k 1.6× 1.6k 2.1× 305 0.8× 344 0.9× 23 3.9k
Shinsuke Yasuda Japan 32 1.8k 0.7× 1.1k 1.1× 993 1.3× 474 1.2× 199 0.5× 163 3.2k
Olivier Vittecoq France 36 2.0k 0.8× 547 0.6× 776 1.0× 581 1.4× 302 0.8× 165 3.5k
Barbara Finck United States 8 2.7k 1.1× 1.5k 1.6× 1.3k 1.7× 268 0.7× 375 1.0× 17 3.6k
Hideto Kameda Japan 38 2.6k 1.1× 1.2k 1.2× 1.2k 1.5× 411 1.0× 631 1.6× 196 4.3k

Countries citing papers authored by Rolf Rau

Since Specialization
Citations

This map shows the geographic impact of Rolf Rau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Rau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Rau more than expected).

Fields of papers citing papers by Rolf Rau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Rau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Rau. The network helps show where Rolf Rau may publish in the future.

Co-authorship network of co-authors of Rolf Rau

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Rau. A scholar is included among the top collaborators of Rolf Rau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Rau. Rolf Rau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wassenberg, Siegfried, Rolf Rau, T. Klopsch, et al.. (2022). Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA). Rheumatology and Therapy. 10(1). 117–133. 3 indexed citations
3.
Herborn, G., Juergen Braun, Henrik Rudolf, et al.. (2017). Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.. PubMed. 35(3). 384–389. 2 indexed citations
4.
Krause, D., et al.. (2016). Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis. Clinical Rheumatology. 35(5). 1123–1127. 4 indexed citations
5.
Krause, D., et al.. (2015). Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis.. PubMed. 33(5). 611–6. 3 indexed citations
6.
Detert, J., Klaus Pietzner, Joachim Listing, et al.. (2014). Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial. Trials. 15(1). 412–412. 18 indexed citations
7.
Rau, Rolf. (2014). Glucocorticoid treatment in rheumatoid arthritis. Expert Opinion on Pharmacotherapy. 15(11). 1575–1583. 26 indexed citations
8.
Strangfeld, Anja, Rolf Rau, Brigitte Krummel-Lorenz, et al.. (2010). Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Research & Therapy. 12(1). R5–R5. 211 indexed citations
9.
Rau, Rolf, et al.. (2007). Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis & Rheumatism. 56(11). 3575–3582. 117 indexed citations
10.
12.
Rau, Rolf. (2004). Have traditional DMARDs had their day?. Clinical Rheumatology. 24(3). 189–202. 28 indexed citations
13.
Sharp, John T., Désirée van der Heijde, Maarten Boers, et al.. (2003). Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions.. PubMed. 30(5). 1102–7. 60 indexed citations
14.
Heijde, Désirée van der, Lee S. Simon, Josef S Smolen, et al.. (2002). How to report radiographic data in randomized clinical trials in rheumatoid arthritis: Guidelines from a roundtable discussion. Arthritis Care & Research. 47(2). 215–218. 121 indexed citations
15.
Rau, Rolf. (2002). Inwieweit bestimmen Studienergebnisse therapeutisches Handeln in der Rheumatologie. Zeitschrift für Rheumatologie. 61(5). 504–515. 2 indexed citations
16.
Rau, Rolf, et al.. (2001). Identification of radiologic healing phenomena in patients with rheumatoid arthritis.. PubMed. 28(12). 2608–15. 57 indexed citations
17.
Putte, Leo van de, Piet L. C. M. van Riel, Alfons A den Broeder, et al.. (1998). A SINGLE DOSE PLACEBO CONTROLLED PHASE I STUDY OF THE FULLY HUMAN ANTI-TNF ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID ARTHRITIS. Arthritis & Rheumatism. 41(9). 21 indexed citations
18.
Bresnihan, Barry, José María Álvaro‐Gracia, Mark Cobby, et al.. (1998). Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis & Rheumatism. 41(12). 2196–2204. 65 indexed citations
19.
Rau, Rolf & G. Herborn. (1996). Healing phenomena of erosive changes in rheumatoid arthritis patients undergoing disease‐modifying antirheumatic drug therapy. Arthritis & Rheumatism. 39(1). 162–168. 47 indexed citations
20.
Rau, Rolf, et al.. (1986). Low-dose methotrexate therapy in rheumatic diseases. KARGER eBooks. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026